Cannabis Law Report

NOVEMBER 4, 2021

The show presented several valuable workshops on critical topics including plant-based going mainstream, esports, supply chains, contract manufacturing, the path forward for hemp/CBD, immune health, the microbiome and natural sweeteners. “We SupplySide East 2022 will be held April 12-13 at the Meadowlands Exposition Center in Secaucus, NJ.

Food 40

Food Events Supply Chain Business 40

Cannabis Law Report

MAY 6, 2022

May 6, 2022. The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Michelle R.E.

THC 52

THC CBD Media Food 52

Cannabis Law Report

DECEMBER 2, 2021

These recommendations will be sent to the Oregon Health Authority (OHA) for consideration during formal rulemaking, with hearings scheduled from February 14 to February 25, 2022. Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours). You can contact Brett Mulligan at ? info@gl-lg.com ? or 503-488-5424.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. At the time of FY 2020 results publication, we estimated that EUR 250m revenues had been lost in FY 2020 due to the impact of COVID-19 lockdowns and travel restrictions and the objective was to recover these revenues by 2022.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: [link] Accessed October 17, 2022. 2020;12(7):1935.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

AUGUST 16, 2021

The Company anticipates this particular account to generate north of $500,000 for 2021 and approximately $1 million or more in 2022. The initial order for approximately $250,000 was shipped in July 2021. HempFusion’s ecommerce business is growing. New customer acquisition increased online by 69.7%

eCommerce 105

eCommerce Retail Research and Development CBD 105

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Igniting the Public Market and Cross-Border Optimism.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

The Cannigma

JULY 9, 2023

The fact that THC binds with important cannabinoid receptors in the brain, and the fact that THC can pass from the mother through the placenta to the developing fetus indeed raises questions about the safety of exposing an unborn baby to THC. A 2022 systematic review and meta-analysis that reviewed data from approximately 5.5

Research and Development 68

Research and Development THC Cannabinoids Topical 68

The Cannigma

OCTOBER 6, 2022

Cannabis use and pregnancy is a tough topic. Refusing to have a conversation around this topic only continues to fuel the stigma of cannabis use. CBD topicals may provide a better option for pregnant and breastfeeding women over Tylenol or other OTC pain medications. THC versus CBD in pregnancy.

CBD 99

CBD Research and Development Topical THC 99

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States. The study will take place in Canada with a CTA filing and enrollment of the first patient anticipated by Q2 of 2022. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

MAY 12, 2022

Berman and Jana Hrdinová write May 11, 2022 . This number grew to 29 schools offering 33 courses in 2019-2020, and growth continued with 35 schools offering 35 courses in 2020-2021 and finally 37 schools offering 38 courses in our most recent accounting in 2021-2022. Edited by: Katherine Gemmingen | U. Pittsburgh School of Law, US.

Law 52

Law Policy State Laws Environment 52

The Cannigma

FEBRUARY 1, 2023

The extract, which has come to be known as Rick Simpson Oil (RSO) , is highly potent, dense, and usually administered orally, sublingually, or topically. Only recently (2022) have laws governing cannabis research in the US become less restrictive. inhalation vs edible) on which we lack clinical data.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

NOVEMBER 29, 2021

As we approach the 2022 legislative session and the elections next November, it is important for lawmakers of all political persuasions to recognize that advocating for marijuana policy reforms is a political opportunity, not a political liability,” NORML’s Paul Armentano said. The law will take effect in January 2022. California.

Legislation 98

Legislation Patients Retail Access 98

Cannabis Law Report

MAY 14, 2022

Access to banking is a well-known issue for the cannabis industry and the repeated efforts to obtain the bill’s congressional passage over the past few years remains a hot topic for industry insiders and participants. The program was officially adopted during the 2022 legislative session.

Banking 52

Banking Recreational Research and Development Cannabis 52